As of 2026-05-22, the Intrinsic Value of Shanghai Kindly Medical Instruments Co Ltd (1501.HK) is 22.31 HKD. This 1501.HK valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 34.04 HKD, the upside of Shanghai Kindly Medical Instruments Co Ltd is -34.50%.
The range of the Intrinsic Value is 16.96 - 32.93 HKD
Based on its market price of 34.04 HKD and our intrinsic valuation, Shanghai Kindly Medical Instruments Co Ltd (1501.HK) is overvalued by 34.50%.
| Range | Selected | Upside | |
| a | |||
| DCF (Growth 5y) | 16.96 - 32.93 | 22.31 | -34.5% |
| DCF (Growth 10y) | 32.15 - 62.87 | 42.49 | 24.8% |
| DCF (EBITDA 5y) | 70.55 - 109.61 | 90.44 | 165.7% |
| DCF (EBITDA 10y) | 86.34 - 146.02 | 114.93 | 237.6% |
| Fair Value | 15.56 - 15.56 | 15.56 | -54.28% |
| P/E | 29.15 - 36.70 | 33.50 | -1.6% |
| EV/EBITDA | 25.36 - 36.53 | 29.78 | -12.5% |
| EPV | (0.76) - (0.84) | (0.80) | -102.4% |
| DDM - Stable | 8.53 - 21.58 | 15.06 | -55.8% |
| DDM - Multi | 21.13 - 42.69 | 28.39 | -16.6% |
| Market Cap (mil) | 7,189.25 |
| Beta | 0.02 |
| Outstanding shares (mil) | 211.20 |
| Enterprise Value (mil) | 7,292.28 |
| Market risk premium | 5.98% |
| Cost of Equity | 10.87% |
| Cost of Debt | 4.25% |
| WACC | 10.61% |